Literature DB >> 19280232

An update on bone substitutes for spinal fusion.

Masashi Miyazaki1, Hiroshi Tsumura, Jeffrey C Wang, Ahmet Alanay.   

Abstract

With the current advances in spinal surgery, an understanding of the precise biological mechanism of each bone substitute is necessary for inducing successful spinal fusion. In this review, the categories of bone substitutes include allografts, ceramics, demineralized bone matrix, osteoinductive factors, autogenous platelet concentrate, mesenchymal stem cells, and gene therapy. Further, clinical studies have been evaluated by their levels of evidence in order to elucidate the precise effect of the bone substitute employed and to establish clinical guidance. This article will review both clinical studies based on evidence and basic research in current advances in order to avoid as far as possible any chances of failure in the future and to understand cellular biology in novel technologies.

Mesh:

Substances:

Year:  2009        PMID: 19280232      PMCID: PMC2899672          DOI: 10.1007/s00586-009-0924-x

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  115 in total

1.  Level of evidence in orthopaedic journals.

Authors:  William T Obremskey; Nick Pappas; Emad Attallah-Wasif; Paul Tornetta; Mohit Bhandari
Journal:  J Bone Joint Surg Am       Date:  2005-12       Impact factor: 5.284

2.  Evaluation of the osteogenesis and biodegradation of porous biphasic ceramic in the human spine.

Authors:  Youzhuan Xie; Daniel Chopin; Christian Morin; Pierre Hardouin; Zhenan Zhu; Jian Tang; Jianxi Lu
Journal:  Biomaterials       Date:  2006-01-19       Impact factor: 12.479

3.  Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study.

Authors:  Alexander R Vaccaro; D Greg Anderson; Tushar Patel; Jeffrey Fischgrund; Eeric Truumees; Harry N Herkowitz; Frank Phillips; Alan Hilibrand; Todd J Albert; Todd Wetzel; John A McCulloch
Journal:  Spine (Phila Pa 1976)       Date:  2005-12-15       Impact factor: 3.468

4.  The efficacy of different commercially available demineralized bone matrix substances in an athymic rat model.

Authors:  Yu-Po Lee; Mark Jo; Mario Luna; Bobby Chien; Jay R Lieberman; Jeffrey C Wang
Journal:  J Spinal Disord Tech       Date:  2005-10

5.  Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.

Authors:  Ben B Pradhan; Hyun W Bae; Edgar G Dawson; Vikas V Patel; Rick B Delamarter
Journal:  Spine (Phila Pa 1976)       Date:  2006-05-01       Impact factor: 3.468

6.  A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.

Authors:  Masahiro Kanayama; Tomoyuki Hashimoto; Keiichi Shigenobu; Shigeru Yamane; Thomas W Bauer; Daisuke Togawa
Journal:  Spine (Phila Pa 1976)       Date:  2006-05-01       Impact factor: 3.468

7.  Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Authors:  Lisa B E Shields; George H Raque; Steven D Glassman; Mitchell Campbell; Todd Vitaz; John Harpring; Christopher B Shields
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

8.  Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.

Authors:  Knut Stieger; Guylène Le Meur; Françoise Lasne; Michel Weber; Jack-Yves Deschamps; Delphine Nivard; Alexandra Mendes-Madeira; Nathalie Provost; Laurent Martin; Philippe Moullier; Fabienne Rolling
Journal:  Mol Ther       Date:  2006-01-25       Impact factor: 11.454

9.  The fusion rate of calcium sulfate with local autograft bone compared with autologous iliac bone graft for instrumented short-segment spinal fusion.

Authors:  Wen-Jer Chen; Tsung-Ting Tsai; Lih-Huei Chen; Chi-Chien Niu; Po-Liang Lai; Tsai-Sheng Fu; Kevin McCarthy
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-15       Impact factor: 3.468

10.  Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment.

Authors:  Tao-Chen Lee; Jih-Tsun Ho; Kuo-Sheng Hung; Wu-Fu Chen; Yueh-Hua Chung; Yu-Lin Yang
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

View more
  33 in total

1.  Effects of a perfusion bioreactor activated novel bone substitute in spine fusion in sheep.

Authors:  Jesper Roed Sørensen; Kariatta Ester Koroma; Ming Ding; David Wendt; Stig Jespersen; Maria Vinther Juhl; Naseem Theilgaard; Ivan Martin; Søren Overgaard
Journal:  Eur Spine J       Date:  2012-07-10       Impact factor: 3.134

2.  The level of evidence in clinical studies of the use of rhBMP-2 in spinal interbody fusions.

Authors:  Tomislav Smoljanovic; Ivana Stipcic; Ivan Bojanic
Journal:  Eur Spine J       Date:  2010-04-28       Impact factor: 3.134

3.  Recommendation for use of rhBMP-2 in spinal interbody fusions.

Authors:  Tomislav Smoljanovic; Ana Aljinovic; Ivan Bojanic
Journal:  Eur Spine J       Date:  2010-04-30       Impact factor: 3.134

4.  Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies.

Authors:  Yujie Lu; Chinmay D Darne; I-Chih Tan; Banghe Zhu; Mary A Hall; Zawaunyka W Lazard; Alan R Davis; Lashan Simpson; Eva M Sevick-Muraca; Elizabeth A Olmsted-Davis
Journal:  Opt Express       Date:  2013-10-07       Impact factor: 3.894

5.  Combining Smoothened Agonist and NEL-Like Protein-1 Enhances Bone Healing.

Authors:  Soonchul Lee; Chenchao Wang; Hsin Chuan Pan; Swati Shrestha; Carolyn Meyers; Catherine Ding; Jia Shen; Eric Chen; Min Lee; Chia Soo; Kang Ting; Aaron W James
Journal:  Plast Reconstr Surg       Date:  2017-06       Impact factor: 4.730

6.  Free vascularised fibular grafting with OsteoSet®2 demineralised bone matrix versus autograft for large osteonecrotic lesions of the femoral head.

Authors:  Yong Feng; Shanzhi Wang; Dongxu Jin; Jiagen Sheng; Shengbao Chen; Xiangguo Cheng; Changqing Zhang
Journal:  Int Orthop       Date:  2009-12-09       Impact factor: 3.075

7.  Demineralized bone matrix, as a graft enhancer of auto-local bone in posterior lumbar interbody fusion.

Authors:  Dong Ki Ahn; Sang Ho Moon; Tae Woo Kim; Kyung Hwan Boo; Sung Won Hong
Journal:  Asian Spine J       Date:  2014-04-08

8.  Efficacy of platelet-rich plasma in posterior lumbar interbody fusion: systematic review and meta-analysis.

Authors:  Saran Pairuchvej; Janisa Andrea Muljadi; Alisara Arirachakaran; Jatupon Kongtharvonskul
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-12-20

Review 9.  A systematic review of comparative studies on bone graft alternatives for common spine fusion procedures.

Authors:  Charla R Fischer; Ryan Cassilly; Winifred Cantor; Emmanuel Edusei; Qusai Hammouri; Thomas Errico
Journal:  Eur Spine J       Date:  2013-02-26       Impact factor: 3.134

10.  Platelet-rich plasma in mono-segmental posterior lumbar interbody fusion.

Authors:  J Sys; J Weyler; T Van Der Zijden; P Parizel; J Michielsen
Journal:  Eur Spine J       Date:  2011-07-10       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.